328 related articles for article (PubMed ID: 18617457)
1. [Non-alcoholic fatty liver disease and cardiovascular risk].
Abel T; Fehér J
Orv Hetil; 2008 Jul; 149(28):1299-305. PubMed ID: 18617457
[TBL] [Abstract][Full Text] [Related]
2. [Is non alcoholic steatohepatitis (NASH) part of the metabolic syndrome?].
Fehér J; Németh E; Lengyel G
Orv Hetil; 2004 Jul; 145(29):1499-506. PubMed ID: 15453020
[TBL] [Abstract][Full Text] [Related]
3. [Non-alcoholic fatty liver disease and steatohepatitis].
Pár G; Horváth G; Pár A
Orv Hetil; 2013 Jul; 154(29):1124-34. PubMed ID: 23853345
[TBL] [Abstract][Full Text] [Related]
4. [Patomechanisms of hepatic steatosis].
Fülöp P; Paragh G
Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747
[TBL] [Abstract][Full Text] [Related]
5. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
Pár A; Pár G
Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
[TBL] [Abstract][Full Text] [Related]
6. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
[TBL] [Abstract][Full Text] [Related]
7. [Fatty liver and global cardiometabolic risk].
Szollár L
Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306
[TBL] [Abstract][Full Text] [Related]
8. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
Crespo J; Cayón A; Pons-Romero F
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
[No Abstract] [Full Text] [Related]
10. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
Rahimi RS; Landaverde C
Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
[TBL] [Abstract][Full Text] [Related]
11. [Influence of non-alcoholic fatty liver disease on cardiovascular disease].
Ampuero J; Romero-Gómez M
Gastroenterol Hepatol; 2012 Oct; 35(8):585-93. PubMed ID: 22541252
[TBL] [Abstract][Full Text] [Related]
12. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
Byrne CD
Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease.
Leclercq I
Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
Ezquer M; Ezquer F; Ricca M; Allers C; Conget P
J Hepatol; 2011 Nov; 55(5):1112-20. PubMed ID: 21356258
[TBL] [Abstract][Full Text] [Related]
15. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
Balmer ML; Dufour JF
Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.
Targher G; Arcaro G
Atherosclerosis; 2007 Apr; 191(2):235-40. PubMed ID: 16970951
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
Federico A; Trappoliere M; Loguercio C
Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
19. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview].
Macías-Rodríguez RU; Torre A
Rev Invest Clin; 2009; 61(2):161-72. PubMed ID: 19637730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
